These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 17227621)
41. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets. Shibata H; Yoshida H; Izutsu K; Goda Y J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275 [TBL] [Abstract][Full Text] [Related]
42. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets. Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278 [TBL] [Abstract][Full Text] [Related]
43. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles. Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282 [TBL] [Abstract][Full Text] [Related]
44. Gas production after reaction of sodium bicarbonate and hydrochloric acid. Fordtran JS; Morawski SG; Santa Ana CA; Rector FC Gastroenterology; 1984 Nov; 87(5):1014-21. PubMed ID: 6090255 [TBL] [Abstract][Full Text] [Related]
46. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. Hamdani J; Moës AJ; Amighi K Int J Pharm; 2006 Sep; 322(1-2):96-103. PubMed ID: 16824707 [TBL] [Abstract][Full Text] [Related]
47. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study. Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242 [TBL] [Abstract][Full Text] [Related]
48. Design and evaluation of floating multi-layer coated tablets based on gas formation. Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527 [TBL] [Abstract][Full Text] [Related]
49. Dissolution of omeprazole from delayed-release solid oral dosage forms. Farinha A; Bica A; Martins JM; Pais JP Drug Dev Ind Pharm; 2000 Jul; 26(7):785-90. PubMed ID: 10872100 [TBL] [Abstract][Full Text] [Related]
50. Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride. Basak SC; Rahman J; Ramalingam M Pharmazie; 2007 Feb; 62(2):145-8. PubMed ID: 17341036 [TBL] [Abstract][Full Text] [Related]
51. Design and evaluation of polymeric coated minitablets as multiple unit gastroretentive floating drug delivery systems for furosemide. Meka L; Kesavan B; Kalamata VN; Eaga CM; Bandari S; Vobalaboina V; Yamsani MR J Pharm Sci; 2009 Jun; 98(6):2122-32. PubMed ID: 19009598 [TBL] [Abstract][Full Text] [Related]
52. Effects of Enteric-Coated Formulation of Sodium Bicarbonate on Bicarbonate Absorption and Gastrointestinal Discomfort. Jiang FL; Jeong DH; Eom SH; Lee HM; Cha BJ; Park JS; Kwon R; Nam JY; Yu HS; Heo SH; Kim CH; Song KH Nutrients; 2024 Mar; 16(5):. PubMed ID: 38474872 [TBL] [Abstract][Full Text] [Related]
53. Eight enteric-coated 50 mg diclofenac sodium tablet formulations marketed in Saudi Arabia: in vitro quality evaluation. Hammami MM; Hussein RF; AlSwayeh R; Alvi SN BMC Res Notes; 2020 Sep; 13(1):428. PubMed ID: 32928294 [TBL] [Abstract][Full Text] [Related]
54. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability. Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644 [TBL] [Abstract][Full Text] [Related]
55. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
56. Effect of sodium bicarbonate on the properties of metronidazole floating matrix tablets. Gutiérrez-Sánchez PE; Hernández-León A; Villafuerte-Robles L Drug Dev Ind Pharm; 2008 Feb; 34(2):171-80. PubMed ID: 18302036 [TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo evaluation of ofloxacin sustained release pellets. Cui Y; Zhang Y; Tang X Int J Pharm; 2008 Aug; 360(1-2):47-52. PubMed ID: 18538518 [TBL] [Abstract][Full Text] [Related]
58. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation. Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270 [TBL] [Abstract][Full Text] [Related]
59. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets. Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147 [TBL] [Abstract][Full Text] [Related]
60. Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation. Roth W; Setnik B; Zietsch M; Burst A; Breitenbach J; Sellers E; Brennan D Int J Pharm; 2009 Feb; 368(1-2):72-5. PubMed ID: 18992310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]